Status:
COMPLETED
Prevalence and Impact of Depression and Anxiety in Cystic Fibrosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Vaincre la Mucoviscidose
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
14-17 years
Brief Summary
The Impact of cystic fibrosis (CF) on psychological and emotional functioning has been the focus of several studies over the past 20 years. The results from a current meta-analysis indicated that depr...
Detailed Description
Numerous studies have demonstrated that patients with chronic illnesses are at increased risk for depression and anxiety. In large, well-controlled epidemiological studies, rates of depression in medi...
Eligibility Criteria
Inclusion
- Patient with CF
- 14 to 17 year old
- Parents of a included patient
Exclusion
- \- Patient who have received an organ transplant shall be excluded.
Key Trial Info
Start Date :
November 23 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 11 2019
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03424486
Start Date
November 23 2017
End Date
July 11 2019
Last Update
December 4 2020
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
CRCM - Service de Pneumologie Pédiatrique - CHU Amiens - Site Sud
Amiens, France, 80000
2
CRCM Enfants - Service de Pneumologie - Hôpital Jean Minjoz
Besançon, France, 25000
3
CRCM Pédiatrique - Hôpital des Enfants
Bordeaux, France, 33000
4
CRCM - Service de Pédiatrie - Pôle FEH - CHU Caen)
Caen, France, 14000